Your browser doesn't support javascript.
loading
Novel multiple sclerosis susceptibility loci implicated in epigenetic regulation.
Andlauer, Till F M; Buck, Dorothea; Antony, Gisela; Bayas, Antonios; Bechmann, Lukas; Berthele, Achim; Chan, Andrew; Gasperi, Christiane; Gold, Ralf; Graetz, Christiane; Haas, Jürgen; Hecker, Michael; Infante-Duarte, Carmen; Knop, Matthias; Kümpfel, Tania; Limmroth, Volker; Linker, Ralf A; Loleit, Verena; Luessi, Felix; Meuth, Sven G; Mühlau, Mark; Nischwitz, Sandra; Paul, Friedemann; Pütz, Michael; Ruck, Tobias; Salmen, Anke; Stangel, Martin; Stellmann, Jan-Patrick; Stürner, Klarissa H; Tackenberg, Björn; Then Bergh, Florian; Tumani, Hayrettin; Warnke, Clemens; Weber, Frank; Wiendl, Heinz; Wildemann, Brigitte; Zettl, Uwe K; Ziemann, Ulf; Zipp, Frauke; Arloth, Janine; Weber, Peter; Radivojkov-Blagojevic, Milena; Scheinhardt, Markus O; Dankowski, Theresa; Bettecken, Thomas; Lichtner, Peter; Czamara, Darina; Carrillo-Roa, Tania; Binder, Elisabeth B; Berger, Klaus.
Afiliação
  • Andlauer TF; Max Planck Institute of Psychiatry, 80804 Munich, Germany.; Munich Cluster for Systems Neurology (SyNergy), 81377 Munich, Germany.
  • Buck D; Department of Neurology, Klinikum rechts der Isar, Technical University of Munich, 81675 Munich, Germany.
  • Antony G; Central Information Office KKNMS, Philipps University Marburg, 35043 Marburg, Germany.
  • Bayas A; Department of Neurology, Klinikum Augsburg, 86156 Augsburg, Germany.
  • Bechmann L; Department of Neurology, University of Leipzig, 04103 Leipzig, Germany.; Institute of Medical Microbiology, Otto-von-Guericke University, 39120 Magdeburg, Germany.
  • Berthele A; Department of Neurology, Klinikum rechts der Isar, Technical University of Munich, 81675 Munich, Germany.
  • Chan A; Department of Neurology, St. Josef Hospital, Ruhr-University Bochum, 44791 Bochum, Germany.; Department of Neurology, University Hospital Bern and University of Bern, 3010 Bern, Switzerland.
  • Gasperi C; Department of Neurology, Klinikum rechts der Isar, Technical University of Munich, 81675 Munich, Germany.
  • Gold R; Department of Neurology, St. Josef Hospital, Ruhr-University Bochum, 44791 Bochum, Germany.
  • Graetz C; Department of Neurology, Focus Program Translational Neurosciences (FTN) and Research Center for Immunotherapy (FZI), Rhine-Main Neuroscience Network (rmn ), University Medical Center of the Johannes Gutenberg University Mainz, 55131 Mainz, Germany.
  • Haas J; Department of Neurology, University Hospital Heidelberg, 69120 Heidelberg, Germany.
  • Hecker M; Department of Neurology, University of Rostock, 18147 Rostock, Germany.
  • Infante-Duarte C; NeuroCure Clinical Research Center, Department of Neurology, and Experimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine, and Charité University Medicine Berlin, 10117 Berlin, Germany.
  • Knop M; Max Planck Institute of Psychiatry, 80804 Munich, Germany.
  • Kümpfel T; Institute of Clinical Neuroimmunology, Ludwigs-Maximilians-Universität, 81377 Munich, Germany.
  • Limmroth V; Department of Neurology, Hospital Köln-Merheim, 51109 Köln, Germany.
  • Linker RA; Department of Neurology, University Hospital Erlangen, 91054 Erlangen, Germany.
  • Loleit V; Department of Neurology, Klinikum rechts der Isar, Technical University of Munich, 81675 Munich, Germany.
  • Luessi F; Department of Neurology, Focus Program Translational Neurosciences (FTN) and Research Center for Immunotherapy (FZI), Rhine-Main Neuroscience Network (rmn ), University Medical Center of the Johannes Gutenberg University Mainz, 55131 Mainz, Germany.
  • Meuth SG; Department of Neurology, Klinik für Allgemeine Neurologie, University of Münster, 48149 Münster, Germany.
  • Mühlau M; Munich Cluster for Systems Neurology (SyNergy), 81377 Munich, Germany.; Department of Neurology, Klinikum rechts der Isar, Technical University of Munich, 81675 Munich, Germany.
  • Nischwitz S; Max Planck Institute of Psychiatry, 80804 Munich, Germany.
  • Paul F; NeuroCure Clinical Research Center, Department of Neurology, and Experimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine, and Charité University Medicine Berlin, 10117 Berlin, Germany.
  • Pütz M; Clinical Neuroimmunology Group, Department of Neurology, Philipps-University of Marburg, 35043 Marburg, Germany.
  • Ruck T; Department of Neurology, Klinik für Allgemeine Neurologie, University of Münster, 48149 Münster, Germany.
  • Salmen A; Department of Neurology, St. Josef Hospital, Ruhr-University Bochum, 44791 Bochum, Germany.; Department of Neurology, University Hospital Bern and University of Bern, 3010 Bern, Switzerland.
  • Stangel M; Department of Neurology, Hannover Medical School, 30625 Hannover, Germany.
  • Stellmann JP; Institute of Neuroimmunology and Multiple Sclerosis and Department of Neurology, University Medical Centre Hamburg-Eppendorf, 20251 Hamburg, Germany.
  • Stürner KH; Institute of Neuroimmunology and Multiple Sclerosis and Department of Neurology, University Medical Centre Hamburg-Eppendorf, 20251 Hamburg, Germany.
  • Tackenberg B; Clinical Neuroimmunology Group, Department of Neurology, Philipps-University of Marburg, 35043 Marburg, Germany.
  • Then Bergh F; Department of Neurology and Translational Center for Regenerative Medicine, University of Leipzig, 04103 Leipzig, Germany.
  • Tumani H; Department of Neurology, University of Ulm, 89081 Ulm, Germany.; Neurological Clinic Dietenbronn, 88477 Schwendi, Germany.
  • Warnke C; Department of Neurology, Medical Faculty, Heinrich Heine University, 40225 Düsseldorf, Germany.
  • Weber F; Max Planck Institute of Psychiatry, 80804 Munich, Germany.; Neurological Clinic, Medical Park, 65520 Bad Camberg, Germany.
  • Wiendl H; Department of Neurology, Klinik für Allgemeine Neurologie, University of Münster, 48149 Münster, Germany.
  • Wildemann B; Department of Neurology, University Hospital Heidelberg, 69120 Heidelberg, Germany.
  • Zettl UK; Department of Neurology, University of Rostock, 18147 Rostock, Germany.
  • Ziemann U; Department of Neurology and Stroke, and Hertie Institute for Clinical Brain Research, Eberhard-Karls-Universität Tübingen, 72076 Tübingen, Germany.
  • Zipp F; Department of Neurology, Focus Program Translational Neurosciences (FTN) and Research Center for Immunotherapy (FZI), Rhine-Main Neuroscience Network (rmn ), University Medical Center of the Johannes Gutenberg University Mainz, 55131 Mainz, Germany.
  • Arloth J; Max Planck Institute of Psychiatry, 80804 Munich, Germany.; Institute of Computational Biology, Helmholtz Zentrum München, 85764 Neuherberg, Germany.
  • Weber P; Max Planck Institute of Psychiatry, 80804 Munich, Germany.
  • Radivojkov-Blagojevic M; Institute of Human Genetics, Helmholtz Zentrum München, 85764 Neuherberg, Germany.
  • Scheinhardt MO; Institut für Medizinische Biometrie und Statistik, Universität zu Lübeck, Universitätsklinikum Schleswig-Holstein, Campus Lübeck, 23562 Lübeck, Germany.
  • Dankowski T; Institut für Medizinische Biometrie und Statistik, Universität zu Lübeck, Universitätsklinikum Schleswig-Holstein, Campus Lübeck, 23562 Lübeck, Germany.
  • Bettecken T; Max Planck Institute of Psychiatry, 80804 Munich, Germany.
  • Lichtner P; Institute of Human Genetics, Helmholtz Zentrum München, 85764 Neuherberg, Germany.; Institute of Human Genetics, Technische Universität München, 81675 Munich, Germany.
  • Czamara D; Max Planck Institute of Psychiatry, 80804 Munich, Germany.
  • Carrillo-Roa T; Max Planck Institute of Psychiatry, 80804 Munich, Germany.
  • Binder EB; Max Planck Institute of Psychiatry, 80804 Munich, Germany.; Department of Psychiatry and Behavioral Sciences, Emory University, Atlanta, GA 30329, USA.
  • Berger K; Institut für Epidemiologie und Sozialmedizin der Universität Münster, 48149 Münster, Germany.
Sci Adv ; 2(6): e1501678, 2016 06.
Article em En | MEDLINE | ID: mdl-27386562

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Predisposição Genética para Doença / Epigênese Genética / Esclerose Múltipla Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Predisposição Genética para Doença / Epigênese Genética / Esclerose Múltipla Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article